TScan Therapeutics Ownership | Who Owns TScan Therapeutics?
TScan Therapeutics Ownership Summary
TScan Therapeutics is owned by 27.53% institutional investors, 0.23% insiders, and 72.24% retail investors. Blackrock is the largest institutional shareholder, holding 4.70% of TCRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.36% of its assets in TScan Therapeutics shares.
TCRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | TScan Therapeutics | 27.53% | 0.23% | 72.24% |
| Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
| Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 4.46M | 4.70% | $26.10M |
| Lynx1 capital management lp | 5.36M | 4.51% | $16.29M |
| Ecor1 capital | 5.00M | 4.21% | $15.20M |
| Bvf inc/il | 5.23M | 4.03% | $7.58M |
| Baker bros. advisors lp | 2.78M | 2.15% | $4.04M |
| Vanguard group | 2.38M | 2.01% | $7.24M |
| Blackrock funding, inc. /de | 2.57M | 1.98% | $3.72M |
| Propel bio management | 2.09M | 1.61% | $3.03M |
| Deer management | 1.25M | 0.96% | $1.81M |
| Alphabet | 1.08M | 0.83% | $1.56M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Dc funds, lp | 630.00K | 42.43% | $913.50K |
| Lynx1 capital management lp | 5.36M | 6.11% | $16.29M |
| Propel bio management | 2.09M | 3.67% | $3.03M |
| Ecor1 capital | 5.00M | 0.57% | $15.20M |
| Bvf inc/il | 5.23M | 0.27% | $7.58M |
| Deer management | 1.25M | 0.14% | $1.81M |
| Simplify asset management | 1.05M | 0.08% | $1.52M |
| Alphabet | 1.08M | 0.07% | $1.56M |
| Militia capital partners, lp | 94.30K | 0.06% | $136.74K |
| Troluce capital advisors | 150.00K | 0.05% | $217.50K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 4.46M | 0.00% | 2.76M |
| State street | 608.09K | 0.00% | 473.08K |
| Bvf inc/il | 5.23M | 0.27% | 336.60K |
| Citadel advisors | 157.96K | 0.00% | 146.53K |
| Dimensional fund advisors lp | 280.03K | 0.00% | 145.73K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | - | - | -3.50M |
| Blackrock funding, inc. /de | 2.57M | 0.00% | -2.31M |
| Checkpoint capital | - | - | -2.02M |
| Great point partners | - | - | -1.02M |
| Stempoint capital lp | - | - | -860.95K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Militia capital partners, lp | 94.30K | 0.06% | 94.30K | $136.74K |
| Y-intercept (hong kong) | 76.66K | 0.00% | 76.66K | $111.16K |
| Bnp paribas arbitrage, snc | 65.14K | 0.00% | 65.14K | $198.02K |
| Hrt financial lp | 55.37K | 0.00% | 55.37K | $80.00K |
| Point72 asia (singapore) pte. | 29.07K | 0.01% | 29.07K | $42.15K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -7.00 |
| Federated hermes | -56.00 |
| Rothschild investment | -110.00 |
| Gamma investing | -142.00 |
| Corecap advisors | -166.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 78 | -12.36% | 35,711,883 | -7.86% | 27 | 3.08% | 46 | -6.12% | 17 | -5.56% |
| Mar 31, 2025 | 92 | 4.55% | 40,135,892 | -3.36% | 30 | 2.53% | 50 | 6.38% | 19 | 18.75% |
| Dec 31, 2024 | 27 | -68.60% | 11,233,656 | -73.15% | 9 | 0.76% | 13 | -71.11% | 5 | -68.75% |
| Sep 30, 2024 | 86 | 10.26% | 41,835,445 | 0.96% | 35 | 1.85% | 45 | -8.16% | 16 | 23.08% |
| Jun 30, 2024 | 78 | 18.18% | 41,438,662 | 20.84% | 43 | 1.60% | 49 | 25.64% | 13 | 44.44% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.34M | 2.36% | -29.61K |
| BlackRock Health Sciences Term Trust | 1.05M | 1.85% | - |
| Simplify Propel Opportunities ETF | 1.05M | 1.84% | - |
| BlackRock Health Sciences Opps Inv A | 650.52K | 1.15% | - |
| Invesco Dorsey Wright SmallCap Momt ETF | 475.53K | 0.90% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 500.00K | 0.88% | -206.08K |
| abrdn Healthcare Investors | 498.01K | 0.88% | - |
| Fidelity Small Cap Index | 392.73K | 0.69% | - |
| abrdn Life Sciences Investors | 393.44K | 0.69% | - |
| Fidelity Extended Market Index | 283.36K | 0.50% | -740.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 19, 2025 | Lynx1 Capital Management LP | - | Buy | $1.67M |
| May 20, 2025 | Lynx1 Capital Management LP | - | Buy | $1.44M |
| Dec 26, 2024 | Lynx1 Capital Management LP | - | Buy | $750.00 |
| Dec 13, 2024 | Lynx1 Capital Management LP | - | Buy | $290.14K |
| Dec 12, 2024 | Lynx1 Capital Management LP | - | Buy | $95.63K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 2 | - |
| 2025 Q1 | - | - |
| 2024 Q4 | 4 | - |
| 2024 Q3 | 3 | 1 |
| 2024 Q2 | 3 | - |
TCRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools